Ci Investments Inc. Bausch Health Companies Inc. Transaction History

Ci Investments Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $1,854 - $3,730	-405 Reduced 96.66%	14 $0
Q2 2022 Aug 12, 2022	SELL	$7.06 - $23.63 $156,710 - $524,515	-22,197 Reduced 98.15%	419 $4,000
Q1 2022 May 12, 2022	SELL	$21.6 - $27.79 $1,814 - $2,334	-84 Reduced 0.37%	22,616 $517,000
Q4 2021 Feb 11, 2022	BUY	$23.0 - $29.01 $461,863 - $582,549	20,081 Added 766.74%	22,700 $627,000
Q3 2021 Nov 12, 2021	BUY	$25.04 - $30.06 $65,579 - $78,727	2,619 New	2,619 $73,000
Q1 2021 May 13, 2021	SELL	$21.37 - $34.38 $692,388 - $1.11 Million	-32,400 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$15.31 - $21.12 $68,895 - $95,040	-4,500 Reduced 12.2%	32,400 $674,000
Q3 2020 Nov 09, 2020	BUY	$14.88 - $20.13 $549,072 - $742,797	36,900 New	36,900 $573,000
Q1 2020 Aug 07, 2020	SELL	$12.98 - $30.25 $110,330 - $257,125	-8,500 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$18.89 - $31.89 $160,565 - $271,065	8,500 New	8,500 $330,000

258

255M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.79B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Ci Investments Inc. with notifications on news.